These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 22116018)

  • 61. Esophageal cancer: The latest on chemoprevention and state of the art therapies.
    Le Bras GF; Farooq MH; Falk GW; Andl CD
    Pharmacol Res; 2016 Nov; 113(Pt A):236-244. PubMed ID: 27565381
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Clinical observation of gene expression-guided chemoradiation therapy for nonsurgical esophageal squamous cell carcinoma patients: a retrospective analysis of 36 cases.
    Yang Z; Dai H; Lv D; Feng AL; Shu W; Han J
    Onco Targets Ther; 2016; 9():4561-8. PubMed ID: 27524911
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Non-surgical versus surgical treatment for oesophageal cancer.
    Best LM; Mughal M; Gurusamy KS
    Cochrane Database Syst Rev; 2016 Mar; 3(3):CD011498. PubMed ID: 27021481
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Comparison between surgery and definitive chemoradiotherapy for patients with resectable esophageal squamous cell carcinoma: a propensity score analysis.
    Nomura M; Oze I; Kodaira T; Abe T; Komori A; Narita Y; Masuishi T; Taniguchi H; Kadowaki S; Ura T; Andoh M; Tachibana H; Uemura N; Tajika M; Niwa Y; Muto M; Muro K
    Int J Clin Oncol; 2016 Oct; 21(5):890-898. PubMed ID: 26980212
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Impact of Treatment Modalities on Survival of Patients With Locoregional Esophageal Squamous-Cell Carcinoma in Taiwan.
    Chen HS; Hung WH; Ko JL; Hsu PK; Liu CC; Wu SC; Lin CH; Wang BY
    Medicine (Baltimore); 2016 Mar; 95(10):e3018. PubMed ID: 26962818
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The influence of dose distribution on treatment outcome in the SCOPE 1 oesophageal cancer trial.
    Carrington R; Spezi E; Gwynne S; Dutton P; Hurt C; Staffurth J; Crosby T
    Radiat Oncol; 2016 Feb; 11():19. PubMed ID: 26852238
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The role of PD-L1 in the radiation response and prognosis for esophageal squamous cell carcinoma related to IL-6 and T-cell immunosuppression.
    Chen MF; Chen PT; Chen WC; Lu MS; Lin PY; Lee KD
    Oncotarget; 2016 Feb; 7(7):7913-24. PubMed ID: 26761210
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Long-term results of chemoradiotherapy for stage II-III thoracic esophageal cancer in a single institution after 2000 -with a focus on comparison of three protocols.
    Umezawa R; Jingu K; Matsushita H; Sugawara T; Kubozono M; Yamamoto T; Ishikawa Y; Kozumi M; Takahashi N; Katagiri Y; Kadoya N; Takeda K; Ariga H; Nemoto K; Yamada S
    BMC Cancer; 2015 Oct; 15():813. PubMed ID: 26506988
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Chemoradiotherapy for T4 and/or M1 lymph node esophageal cancer: experience since 2000 at a high-volume center in Japan.
    Jingu K; Umezawa R; Matsushita H; Sugawara T; Kubozono M; Yamamoto T; Ishikawa Y; Kozumi M; Takahashi N; Katagiri Y; Kadoya N; Takeda K
    Int J Clin Oncol; 2016 Apr; 21(2):276-282. PubMed ID: 26324841
    [TBL] [Abstract][Full Text] [Related]  

  • 70. High FDG uptake areas on pre-radiotherapy PET/CT identify preferential sites of local relapse after chemoradiotherapy for locally advanced oesophageal cancer.
    Calais J; Dubray B; Nkhali L; Thureau S; Lemarignier C; Modzelewski R; Gardin I; Di Fiore F; Michel P; Vera P
    Eur J Nucl Med Mol Imaging; 2015 May; 42(6):858-67. PubMed ID: 25680400
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Cancer of the oesophagus and gastroesophageal junction - a difficult clinical problem.
    Głuszek S; Kot M; Kotucha B; Stępień R; Kozieł D
    Contemp Oncol (Pozn); 2014; 18(5):349-54. PubMed ID: 25477759
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Intensity modulated radiotherapy (IMRT) with concurrent chemotherapy as definitive treatment of locally advanced esophageal cancer.
    Roeder F; Nicolay NH; Nguyen T; Saleh-Ebrahimi L; Askoxylakis V; Bostel T; Zwicker F; Debus J; Timke C; Huber PE
    Radiat Oncol; 2014 Aug; 9():191. PubMed ID: 25175056
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Esophageal cancer management controversies: Radiation oncology point of view.
    Tai P; Yu E
    World J Gastrointest Oncol; 2014 Aug; 6(8):263-74. PubMed ID: 25132924
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The role of induction therapy.
    Moremen JR; Skopelja EN; Ceppa DP
    J Thorac Dis; 2014 May; 6 Suppl 3(Suppl 3):S309-13. PubMed ID: 24876935
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Feasibility of intensity-modulated and image-guided radiotherapy for locally advanced esophageal cancer.
    Nguyen NP; Jang S; Vock J; Vinh-Hung V; Chi A; Vos P; Pugh J; Vo RA; Ceizyk M; Desai A; Smith-Raymond L;
    BMC Cancer; 2014 Apr; 14():265. PubMed ID: 24742268
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Combined modality treatment of oesophageal cancer].
    Stahl M; Ruhstaller T
    Internist (Berl); 2014 Jan; 55(1):7-8, 10-4. PubMed ID: 24154497
    [TBL] [Abstract][Full Text] [Related]  

  • 77. IL-6 expression predicts treatment response and outcome in squamous cell carcinoma of the esophagus.
    Chen MF; Chen PT; Lu MS; Lin PY; Chen WC; Lee KD
    Mol Cancer; 2013 Apr; 12():26. PubMed ID: 23561329
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Multidrug resistance in primary tumors and metastases in patients with esophageal squamous cell carcinoma.
    Qiang F; Guangguo R; Yongtao H; Dandan D; Hong Y
    Pathol Oncol Res; 2013 Oct; 19(4):641-8. PubMed ID: 23508648
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Advanced techniques in neoadjuvant radiotherapy allow dose escalation without increased dose to the organs at risk : Planning study in esophageal carcinoma.
    Fakhrian K; Oechsner M; Kampfer S; Schuster T; Molls M; Geinitz H
    Strahlenther Onkol; 2013 Apr; 189(4):293-300. PubMed ID: 23443611
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Immunotherapy for gastrointestinal malignancies.
    Toomey PG; Vohra NA; Ghansah T; Sarnaik AA; Pilon-Thomas SA
    Cancer Control; 2013 Jan; 20(1):32-42. PubMed ID: 23302905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.